Continuing Versus New Prescriptions for Sedative-Hypnotic Medications: United States, 2005–2012
نویسندگان
چکیده
منابع مشابه
155 - Sedative-Hypnotic Agents
Barbiturates were formerly the primary sedative-hypnotic agents used clinically. Currently, they are most often encountered as anticonvulsants, induction agents for anesthesia, and agents used for procedural sedation. Because the barbiturates have largely been replaced clinically by benzodiazepines due to safety concerns, their prevalence in overdoses has drastically decreased when compared wit...
متن کاملHigh Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults.
BACKGROUND Benzodiazepines and sedative hypnotics are commonly used to treat insomnia and agitation in older adults despite significant risk. A clear understanding of the extent of the problem and its contributors is required to implement effective interventions. OBJECTIVE To determine the proportion of hospitalized older adults who are inappropriately prescribed benzodiazepines or sedative h...
متن کاملSedative-Hypnotic and Anxiolytic Drugs
The primary use of sedative–hypnotic and anxiolytic drugs is to encourage calmness (anxiolytics or sedatives) or to produce sleep (sedative–hypnotics). All people are subject to states of emotional tension and uneasiness. For otherwise healthy individuals, these occasions are usually sufficiently mild and short that pharmacological intervention is unnecessary. However, at times the symptoms of ...
متن کاملAre extrasynaptic GABAA receptors important targets for sedative/hypnotic drugs?
High-affinity extrasynaptic GABA(A) receptors are persistently activated by the low ambient GABA levels that are known to be present in extracellular space. The resulting tonic conductance generates a form of shunting inhibition that is capable of altering cellular and network behavior. It has been suggested that this tonic inhibition will be enhanced by neurosteroids, antiepileptics, and sedat...
متن کاملEvidence of continuing methylchloroform emissions from the United States
[1] We present measurements from three sites during 2001–2002 showing that methylchloroform emissions have continued in the U.S., despite the 1996 production ban under the Montreal Protocol. Available data from urban regions, if representative, suggest that 1997–2002 U.S. emissions declined exponentially from 18.5 to 3.0 Gg/yr. F-11 also showed evidence of ongoing emissions, whereas F-113 emiss...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Public Health
سال: 2016
ISSN: 0090-0036,1541-0048
DOI: 10.2105/ajph.2016.303382